Subscribe to The Daily Advance RSS Feed Mobile Access E-Newsletter Log In or Register as a New User 
Classifieds
Automotive
Real Estate
Employment
Merchandise
HEALTH
HealthDay | Archives

New Therapy Freezes Out Esophageal Cancers

New Therapy Freezes Out Esophageal Cancers

Related News from HealthDay
Europe Unlikely to Meet Measles Goals: Report
’Snowbirds’ Beware the Climate Changes
Health Tip: More Than You Can Chew
Deep Brain Stimulation Helps Those With Advanced Parkinson’s
Health Care Spending in U.S. Grew at Lowest Rate in a Decade
Implanted Defibrillators Benefit Older People
Health News Archives
   

FRIDAY, Aug. 8 (HealthDay News) -- A new method of freezing damaged cells in the esophagus to prevent them from turning cancerous is being used by gastroenterologists at the University of Texas Southwestern Medical Center at Dallas.

A condition called Barrett's esophagus can result from ongoing heartburn, in which stomach acid constantly splashes into the esophagus. Untreated, this can become Barrett's with dysplasia, in which cells start to transform.

"Due to damage from chronic stomach acid, they are people who have a higher risk of developing esophagus cancer. The goal of this therapy is to literally freeze the damage in its tracks and stop it before it turns to cancer," Dr. Jayaprakash Sreenarasimhaiah, an assistant professor of internal medicine in the division of digestive and liver diseases, said in a UT Southwestern news release.

In this U.S. Food and Drug Administration-approved treatment, a special catheter is used to spray liquid nitrogen on the damaged tissue to freeze the lining of the esophagus. The treated tissue falls away, allowing normal cells to grow and replace the damaged cells in about six to eight weeks.

Patients are sedated for the cryoablation therapy, which takes about 30 to 40 minutes.

Typical treatment for Barrett's esophagus with dysplasia has included mucosal resection, in which the damaged lining is scraped away. This procedure can take hours and cause side effects such as bleeding or narrowing of the esophagus. In some cases, patients have surgery to remove the damaged sections of the esophagus. However, some patients are too sick or elderly for surgery while others want another option.

"This is a disease we see in a lot of older patients with other illnesses, so the decision to send them to surgery requires careful consideration. Cryoablation therapy is particularly attractive for older patients who may have complications or other medical issues -- such as accompanying heart or lung diseases -- that make traditional surgeries for Barrett's with dysplasia too risky," Sreenarasimhaiah said.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about Barrett's esophagus.

 

Copyright © 2008 ScoutNews, LLC. All rights reserved.



HELPFUL TOOLS

Analyze Yourself

Calculate your body mass.
Analyze yourself for depression.
Rate yourself for thyroid disease.
Do you have a sinus infection?




Marshall News Messenger Top Cars
Pontiac Grand Prix,3.8L V6 12V MPFI OHV, Midsize Car...(more) 
Dodge Ram 1500 Truck,4.7L V8 16V SOHC, Standard Pickup Truck...(more) 
Chevrolet Aveo,1.6L I4 16V MPFI DOHC, Subcompact Car...(more) 
Chevrolet Colorado,3.5L I5 20V DOHC Vortec 220 hp 225 lb-ft torque, Small Pickup Truck...(more) 
Toyota Corolla,1.8L I4 16V MPFI DOHC, Compact Car...(more) 
Chevrolet Cobalt,2.2L I4 16V MPFI DOHC, Compact Car...(more) 
Dodge Grand Caravan,3.3L V6 12V OHV 180 hp 210 lb-ft torque, Special Purpose Vehicle...(more) 
Chevrolet Silverado 1500 Classic,4.3L V6 12V Vortec 195hp @ 4600 rpm, 260 ft-lb torque @ 2800 rpm, Standard Pickup Truck...(more) 
-View All Top Cars-
-Place an Ad-
 

Marshall News | Marshall Weather | Sports | Lifestyle | Business News | Opinions | Classifieds | Sitemap
Marshall Cars | Marshall Real Estate | Marshall Jobs

Copyright 2008 Marshall News Messenger. All rights reserved.

By using this service, you accept the terms of our visitor agreement and privacy policy.
Registered site users, you may edit your profile.